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Abstract
Background: Nefang is a polyherbal anti-malarial composed of Mangifera indica (MiB and MiL; bark and leaf),
Psidium guajava (Pg), Carica papaya (Cp), Cymbopogon citratus (Cc), Citrus sinensis (Cs) and Ocimum gratissimum (Og)
(leaves). Previous studies have demonstrated its in vitro and in vivo antiplasmodial activities, antioxidant properties
and safety profile. This study aimed at evaluating the antipyretic, anti-inflammatory and antinociceptive activities of
the constituent plants of Nefang which are relevant to the symptomatic treatment of malaria fever.
Methods: Antipyretic activities were determined by the D-Amphetamine induced pyrexia and Brewer’s Yeast induced
hyperpyrexia methods. Anti-inflammatory activities were investigated using the carrageenan-induced rat paw edema
method. Antinociceptive activities were determined by mechanical nociception in the tail pressure and thermal
nociception in the radiant heat tail flick and hot plate methods. Data was analysed using the one way ANOVA
followed by Neuman-Keuls multiple comparison test.
Results: Best percentage inhibition of induced pyrexia (amphetamine/brewer’s yeast; p < 0.05) was exhibited by
Cc (95/97) followed by Og (85/94), MiL (90/89), MiB (88/84) and Cs (82/89). Cc and Og exhibited comparable
activities to paracetamol (100/95).
Anti-inflammatory studies revealed paw edema inhibition (%) as follows (p < 0.05): Indomethacin (47), MiL (40), Cp
(30), MiB (28) and Og (22), suggesting best activity by MiL.
Antinociceptive studies revealed significant (p < 0.01) pain inhibition (%) as follows: Paracetamol (97), Og (113),
MiL (108), Pg (84) and MiB (88). Og and MiL exhibited the best activities.
Conclusion: The results obtained suggest that the constituent plants possess biologically active compounds with
antipyretic, anti-inflammatory and antinociceptive activities. These activities are essential in the symptomatic treatment
of malaria fever, thereby justifying the folk use of Nefang. This would be useful in its subsequent development for
clinical application.
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Background
Overseas development assistance to low and middle in-
come countries (LMICs) have led to substantial improve-
ment in the number of vulnerable populations protected
against malaria infection, especially in those who have ac-
cess to drugs that effectively treat the disease [1]. In spite
of this, Plasmodium falciparum malaria remains a major
public health burden in most endemic African countries,
where there is lack of access to modern healthcare facil-
ities and disease monitoring is not well defined. The emer-
ging resistance of the parasite to currently available drugs
makes the situation even more complicated. The disease
remains one of the major threats to public health and the
economic development of these countries [2, 3]. Most of
the populations resort to the use of plant-based comple-
mentary medicine for therapy [4].
Natural compounds have provided the best anti-malarials
known to date. Examples include chloroquine from
Cinchona species, artemisinin from Artemisia annua and
atovaquone from Tabebuia impetiginosa [5, 6]. Their ad-
vantage for the development of drugs comes from the syn-
ergistic interactions of their components and their innate
affinity for biological receptors [7]. The pharmacological
justification of these principles could provide the basis for
further development of plant-based traditional medicine
as a reliable therapeutic tool.
Nefang is a polyherbal product composed of Mangifera
indica (bark and leaf), Psidium guajava, Carica papaya,
Cymbopogon citratus, Citrus sinensis and Ocimum gratissi-
mum (leaves). It is frequently used for the treatment of
malaria in the South West Region of Cameroon. Ethno-
pharmacological studies confirmed its formulation, folk
use and a review of the biological activities of its constitu-
ent plants [8]. Use of Nefang for the treatment of malaria
raises the question as to whether the therapeutic effects
are as a result of the antiplasmodial activity of its constitu-
ents or to their ability to ameliorate the symptoms of mal-
aria or a combination of both effects.
Evaluation of the in vitro and in vivo antioxidant prop-
erties of this polyherbal revealed potential free radical
scavenging and antioxidant activities of some constituent
plants. These activities correlated with their phenolic
content and are believed to contribute to the demon-
strated in vivo antioxidant activity of Nefang and play a
role in curbing oxidative stress associated with malaria
infection [9].
The in vitro antiplasmodial activities of this polyherbal
and solvent extracts of its constituent plants has earlier
been evaluated, revealing good activity and potential
synergistic interactions between some of its components
[10]. This synergy is believed to contribute favorably to-
wards its antiplasmodial activity. The good antiplasmo-
dial activity and demonstrated weak cytotoxicity of the
constituent extracts suggested a high selectivity for P.
falciparum. Preliminary phytochemical screening of its
constituent plants revealed the presence of alkaloids, an-
thocyanins, flavonoids, phenols, saponins, tannins, triter-
penes and sterols [10]. The synergy of these active and
non-antiplasmodial compounds is responsible for the
antiplasmodial activity of Nefang.
Our recent studies demonstrated the antimalarial effi-
cacy of Nefang during early and established Plasmodium
infection, revealing good suppression of parasitemia and
chemotherapeutic activities [11]. We have also estab-
lished the in vivo safety profile of Nefang.
This study aimed at providing pharmacological evi-
dence on the folk use of Nefang by evaluating the effects
of its constituent plants on induced pyrexia, inflamma-
tion and nociception in experimental rodent models.
Methods
Extraction of plant material
Fresh parts of the constituent plants of Nefang were
identified and harvested from their natural habitat in
Cameroon. Identification was done by a botanist, Dr.
Tsabang Nole of the Institute of Medical Research and
Medicinal Plants Studies (IMPM), Yaoundé, Cameroon
with voucher specimen references as follows: M. indica
(TN6225), P. guajava (TN6226), C. papaya (TN6227), C.
citratus (TN6228), C. sinensis (TN6229), O. gratissimum
(TN6230). Aqueous extractions were performed as earlier
described [10] using pyrogen-free distilled water. Each fil-
trate was then concentrated in an air oven at 60 °C. The
extracts were weighed and stored in labeled sealed plastic
containers at 4 °C until use.
Experimental animals
Swiss albino mice (20–25 g) were used for testing anti-
nociceptive activity while wistar rats (170 – 200 g) were
used for antipyretic and anti-inflammatory activities.
All experimental animals were housed under standard
environmental conditions of temperature at 22-24 °C
under a 12 h dark–light cycle, and allowed free access to
drinking water and standard pellet diet.
Ethical approval for the study was obtained from
Kenyatta National Hospital/University of Nairobi Ethics
and Research committee, Nairobi-Kenya (KNH-ERC/A/
324 - 5/12/12).
Tests for antipyretic activity
D-Amphetamine induced pyrexia method
The antipyretic activities of the constituent aqueous
plant extracts of Nefang were determined by the D-
Amphetamine induced pyrexia method [12]. Wistar rats
of both sexes were fasted for 24 h. At zero hour, the basal
temperature of all the animals was taken using an infra-
red thermometer. D-amphetamine (5 mgkg−1) was then
administered to all the animals. After 30 min, sixty four
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animals with an increase in body temperature of 0.5 - 1 °C
were selected for the study. They were randomized into
sixteen groups of four rats each. Group 1 was treated with
10 mLkg−1 of the vehicle (normal saline), group 2 - the
reference drug (Paracetamol, 150 mgkg−1) and two groups
for each extract were treated orally with 200 and 400
mgkg−1 bwt of each extract. Body temperatures were ob-
tained at 60, 120, 180 and 240 min after drug administra-
tion. The percentage suppression of induced pyrexia in
the extract-treated groups was compared with that of the
control to evaluate the activity of each extract.
Brewer’s yeast-induced hyperpyrexia method
Brewer’s yeast-induced hyperpyrexia method was used to
determine the antipyretic activities of the constituent
plants of Nefang [13]. Wistar rats of both sexes were
fasted for 24 h and then randomized into sixteen groups
of three rats each. At zero hour, the basal temperature of
each rat was taken using an infra-red thermometer. There-
after, each animal received a subcutaneous injection of 10
mLkg−1 of aqueous yeast suspension (20 % w/v) to elevate
the body temperature. Eighteen hours post yeast injection,
10 mLkg−1 of the standard drug (aspirin, 100 mgkg−1), the
vehicle (normal saline), 200 and 400 mgkg−1 of each aque-
ous extract were administered orally to different groups of
rats. Body temperature of each animal was recorded at 0,
60, 120 and 180 min after drug administration and the ac-
tivity of each extract evaluated.
Test for anti-inflammatory activity
In vivo anti-inflammatory activities of the constituent
plants of Nefang were evaluated using the carrageenan-
induced rat paw edema method [14]. Ninety-two adult
wistar rats were randomly divided into twenty three
groups of four each. Paw volumes were measured at zero
minute using the Archimedes principle of mercury dis-
placement in a plethysmograph. Thereafter, 10 mLkg−1 of
the vehicle (normal saline), the reference drug (Indometh-
acin, 10 mgkg−1), and 100, 200 and 400 mgkg−1 bwt of
each extract were administered orally to different groups
of rats. Thirty minutes later, paw edema was induced in
each rat by injecting 0.1 mL of carrageenan (1 % in normal
saline) to the right hind paw. Paw volumes were measured
at 60, 120, 180 and 240 min. The difference between the
paw volume at zero minute and each time point was taken
as a measure of edema. The percentage inhibition of paw
volumes in extract-treated groups was compared with the
standard drug to evaluate the activity of the extracts.
Tests for antinociceptive activity
Tail pressure method
The method described by Randall and Selitto [15] and
modified by Kitchen [16] was used for the evaluation of
analgesic activities of the constituent extracts. Thirty-six
Swiss albino mice were randomly divided into nine
groups of four each. At zero minute, the tail of each
mouse was put on the tip of an analgesy-meter and pres-
sure gradually increased up to a maximum of 25 units.
The pressure at which the mouse began to struggle was
noted and recorded. Mice in group 1 (positive control)
were treated by intraperitoneal injection with 0.1 mL of
the standard drug (morphine, 5 mgkg−1); group 2 –
phosphate buffered saline (PBS); group 3 – 7 were each
treated with 10 mLkg−1 of 1000 mgkg−1 bwt of each
aqueous plant extract. After 30 min, mechanical pain
was induced on the tail of each restrained mouse in turn
by the use of analgesy-meter. The force was continu-
ously monitored by a pointer moving along a linear
scale. The weight causing pain before treatment (0 min)
and then at 30, 60, 90 and 120 min post extract/drug
treatment was recorded. Percentage pain inhibition (in-
crease in pain threshold) produced relative to the con-
trol group was calculated for each extract-treated group
and compared with the standard drug-treated group,
using the following equation:
Pain inhibition %ð Þ ¼ Ft‐Fo
Fo
 100
Where Ft = Force at which the animal tries to free its
tail after drug administration.
Fo = Force at which the animal tries to free its tail be-
fore drug administration.
Extracts that showed activity were then subjected to
further dose–response testing.
Tail flick response method
The analgesic activity of each of the constituent plants
of Nefang was determined by radiant heat tail-flick
method [17]. The tail flick latency was assessed by an
analgesiometer (Inco, India). Before selecting each
mouse for the test, a baseline reaction was taken by pla-
cing the tip of the tail of each mouse on the radiant heat
source from an analgesiometer. The strength of the
current passing through the naked nichrome wire was
kept constant at 5 amperes. The distance between the
heat source and the mouse tails was 1.5 cm and the ap-
plication site of the heat on the tail was maintained
within 2 cm. Each mouse in turn was held in a suitable
restrainer with tail protruding out. Radiant heat from
the analgesiometer was applied on a designated spot on
the tail. The time interval between the onset of stimulus
and withdrawal (flicking) of the tail was taken as the re-
action time for each mouse. Cut-off reaction time was
10 sec to avoid tissue injury during the process. The ini-
tial flicking time of each group was considered as the
control reading.
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One hundred and ten mice that responded positively
were randomly divided into twenty-two groups of five
each. Group 1 (positive control) was treated with 0.1 mL
of the standard drug (Paracetamol, 10 mgkg−1) while the
rest of the twenty-one groups were divided into three
groups per aqueous extract and administered 300, 600
and 1200 mgkg−1 bwt respectively of each aqueous ex-
tract by intraperitoneal injection. The tip of the tail of
each mouse was then exposed to the heat source from
the analgesiometer and reaction time recorded at inter-
vals of 30 min till 120 min. The percentage of pain in-
hibition was calculated for each extract-treated group
and compared with that of the standard drug-treated
group using the following equation:
Percentage inhibition ¼ Test meanð Þt− Control meanð Þt
Control meanð Þt
 100
Where t = time
Hot plate method
The analgesic activity of each of the constituent plants of
Nefang was tested using the hot plate method described by
Janssen and Jagenea [18], with modifications. Ninety-two
mice were randomly divided into twenty three groups of
four mice each. Group 1 was treated with 0.1 mL of normal
saline, group 2 - the reference drugs (piroxicam, 20 mgkg−1
and pethidine, 50 mgkg−1), while the remaining twenty one
groups were divided into three groups per extract and
treated with 300, 600 and 1200 mgkg−1 bwt of each extract
respectively. An inverted 500 mL glass conical flask on a
clamp and stand was connected by rubber tubing to a hot
water bath with thermostat and pump, to enable free circu-
lation of water. The temperature was regulated to 55 °C,
such that the temperature on the surface of the inverted
conical flask was the same as that of the water bath. Each
mouse was then placed on the conical flask in order to ob-
tain its response to heat-induced nociceptive pain stimulus.
Licking of the forepaws and eventually jumping off the con-
ical flask was taken as an indicator of the animal’s response
to heat-induced nociceptive pain stimulus. The reaction
time for each mouse was recorded in seconds. Readings
were taken at time zero before administration of drugs/ex-
tracts and after that at intervals of 30, 60 and 120 min. Cut
off time in the absence of response was 60 s to avoid tissue
damage. The percentage of pain inhibition was calculated
for each group using the following equation:
Percentage inhibition ¼ Test meanð Þt‐ Control meanð Þt
Control meanð Þt
 100
Where t = time
Statistical analysis
Data are expressed as mean ± standard deviation (SD).
Data were analyzed using Windows SPSS Version 20.0
(SPSS Inc. Chicago, IL, USA). One-way analysis of vari-
ance (ANOVA) followed by Neuman-Keuls multiple
comparison test to identify the differences between
treated groups and controls. The data was considered
significant at P < 0.05.
Results
Antipyretic activity
Effects on D-Amphetamine-induced pyrexia
Antipyretic activities of the constituent plant extracts of
Nefang were evaluated using D-amphetamine induced
pyrexia in experimental animals. The change in body
temperature and the percentage inhibition of induced pyr-
exia by the constituent extracts have been summarized in
Table 1. In rats treated with the standard drug, paraceta-
mol (150 mgkg−1), we observed an initial rise in body
temperature of approximately 1 °C after 30 min. The high-
est rise in body temperature observed after 60 min was
less than 2 °C. However, after 120 min we observed a sig-
nificant (p < 0.05) decrease in body temperature when
compared to the control. This decrease to normal body
temperature after 240 min, was significantly (p < 0.001)
lower when compared to that of the control.
Upon administration of the constituent plant extracts of
Nefang, we observed the same rise in body temperature
after 30 min in all groups, with highest body temperatures
attained after about 60 min. After 120 min, we observed
significant (p < 0.05) decrease in body temperatures in
animals treated with Cc, Og, MiL, MiB and Cs. After
240 min, we observed that Cc exhibited the best activity
with pyrexia inhibition of 95 %, followed by MiL (90), MiB
(88), Og (85) and Cs (82), comparable to the standard
drug, paracetamol (100). Pg and Cp exhibited very weak
antipyretic activities in experimental animals.
Effects on brewer’s yeast-induced hyperpyrexia
Antipyretic activities of the constituent plant extracts of
Nefang were further evaluated using brewer’s yeast-
induced hyperpyrexia in experimental animals. The effect
on the body temperatures and the percentage inhibition of
induced pyrexia by the constituent plant extracts have
been summarized in Table 2. In rats treated with the
standard drug, paracetamol (150 mgkg−1), we observed
the same trend in temperature rise like the previous exer-
cise with D-amphetamine, with body temperatures of ex-
perimental animals coming back to normal after 240 min
and significantly (p < 0.001) lower when compared to that
of the control.
Cc, Og, MiL, MiB and Cs exhibited significant (p < 0.05)
better antipyretic activities while Pg and Cp exhibited
lower activities when compared to the control. At the end
of 240 min, Cc and Og exhibited percentage pyrexia inhib-
ition of 97 and 94, comparable to the activity of the stand-
ard drug paracetamol (95). We observed once again that,
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Body temperature [BT] (°C) and pyrexia inhibition [PI] (%) over time (minutes) x  SD; n ¼ 4ð Þ
30 60 120 180 240
BT PI BT PI BT PI BT PI BT PI
Normal Saline - 34.95 ± 0.33 35.78 ± 0.19 0.0 36.23 ± 0.32 0.0 36.70 ± 0.38 0.0 36.78 ± 0.39 0.0 36.98 ± 0.33 0.0
Paracetamol 150 34.98 ± 0.42 35.85 ± 0.24 15.5 36.18 ± 0.28 15.9 36.08 ± 0.19* 37.1 35.28 ± 0.29* 78.1 34.98 ± 0.17** 100.0
Mangifera indica bark 200 35.03 ± 0.10 36.40 ± 0.14 0.0 35.90 ± 0.22 31.4 35.60 ± 0.16* 67.1 35.45 ± 0.13* 76.7 35.25 ± 0.33* 88.9
400 35.00 ± 0.08 36.55 ± 0.21 0.0 36.03 ± 0.15 19.6 35.68 ± 0.22* 61.4 35.45 ± 0.17* 75.3 35.33 ± 0.24* 84.0
Mangifera indica leaf 200 35.00 ± 0.18 36.05 ± 0.13 0.0 35.98 ± 0.19 23.5 35.75 ± 0.29* 57.1 35.43 ± 0.17* 76.7 35.25 ± 0.26* 87.7
400 35.18 ± 0.34 36.80 ± 0.24 0.0 36.78 ± 0.10 0.0 36.08 ± 0.10* 48.6 35.85 ± 0.45* 63.0 35.38 ± 0.37* 90.1
Psidium guajava leaf 200 35.18 ± 0.39 36.13 ± 0.26 0.0 36.35 ± 0.37 7.8 36.80 ± 0.14 7.1 36.63 ± 0.19 20.5 36.45 ± 0.06 37.0
400 35.15 ± 0.21 36.05 ± 0.19 0.0 36.50 ± 0.54 0.0 36.68 ± 0.13 12.9 36.40 ± 0.14 31.5 36.45 ± 0.33 35.8
Carica papaya leaf 200 35.05 ± 0.48 36.48 ± 0.61 0.0 36.53 ± 0.43 0.0 36.78 ± 0.49 1.4 36.80 ± 0.48 4.1 36.68 ± 0.39 19.8
400 35.00 ± 0.35 36.45 ± 0.52 0.0 36.63 ± 0.93 0.0 36.70 ± 0.22 2.9 36.75 ± 0.52 4.1 36.75 ± 0.37 13.6
Cymbopogon citratus
leaf
200 35.05 ± 0.17 36.10 ± 0.08 0.0 35.88 ± 0.22 35.3 35.50 ± 0.38* 74.3 35.20 ± 0.41* 91.8 35.15 ± 0.17** 95.1
400 34.90 ± 0.29 35.85 ± 0.06 0.0 35.75 ± 0.25 33.3 35.43 ± 0.33* 70.0 35.23 ± 0.42* 82.2 35.20 ± 0.18** 85.2
Citrus sinensis leaf 200 34.90 ± 0.08 35.73 ± 0.13 0.0 36.05 ± 0.13 9.8 35.73 ± 0.15* 52.9 35.50 ± 0.12* 67.1 35.28 ± 0.22** 81.5
400 34.98 ± 0.15 35.93 ± 0.10 0.0 36.08 ± 0.28 13.7 35.88 ± 0.15* 48.6 35.58 ± 0.32* 67.1 35.33 ± 0.22** 82.7
Ocinum gratissimum
leaf
200 34.93 ± 0.13 35.63 ± 0.36 15.1 35.80 ± 0.36 31.4 35.58 ± 0.36* 62.9 35.28 ± 0.66* 80.8 35.28 ± 0.71** 82.7
400 34.90 ± 0.16 35.95 ± 0.17 0.0 36.05 ± 0.17 9.8 35.88 ± 0.13* 44.3 35.25 ± 0.32* 80.8 35.20 ± 0.22** 85.2
Siginificant difference * - p < 0.05. ** - p < 0.001 when compare to the control







Body temperature [BT] (°C) and pyrexia inhibition [PI] (%) over time (minutes) x  SD; n ¼ 4ð Þ
30 60 120 180 240
BT PI BT PI BT PI BT PI BT PI
Normal Saline - 37.00 ± 0.29 37.95 ± 0.21 0.0 38.14 ± 0.38 0.0 38.65 ± 0.32 0.0 38.91 ± 0.11 0.0 38.96 ± 0.54 0
Paracetamol 150 36.90 ± 0.38 37.70 ± 0.45 15.8 37.75 ± 0.33 25.4 37.85 ± 0.28* 42.4 37.47 ± 0.26* 70.2 37.00 ± 0.39** 94.9
Mangifera indica bark 200 36.90 ± 0.31 37.85 ± 0.39 0.0 37.90 ± 0.41 12.3 37.75 ± 0.27* 48.5 37.55 ± 0.25* 66.0 37.20 ± 0.41* 84.7
400 36.95 ± 0.92 37.95 ± 0.27 0.0 38.15 ± 0.54 0.0 37.73 ± 0.31* 52.7 37.50 ± 0.19* 71.2 37.30 ± 0.38* 82.1
Mangifera indica leaf 200 37.00 ± 0.74 37.85 ± 0.16 10.5 37.95 ± 0.37 16.7 37.60 ± 0.18* 63.6 37.35 ± 0.11* 81.7 37.20 ± 0.28* 89.8
400 37.05 ± 0.67 38.45 ± 0.43 0.0 38.60 ± 0.29 0.0 38.25 ± 0.17* 27.3 37.90 ± 0.28* 55.5 37.50 ± 0.19* 77.0
Psidium guajava leaf 200 36.95 ± 0.51 38.00 ± 0.54 0.0 38.40 ± 0.61 0.0 38.70 ± 0.19 0.0 38.65 ± 0.38 11.0 38.50 ± 0.17 20.9
400 37.10 ± 0.33 38.00 ± 0.15 5.3 38.65 ± 0.72 0.0 38.75 ± 0.24 0.0 38.55 ± 0.36 24.1 38.45 ± 0.11 31.1
Carica papaya leaf 200 37.00 ± 0.61 38.25 ± 0.27 0.0 38.60 ± 0.36 0.0 38.68 ± 0.22 0.0 38.65 ± 0.31 13.6 38.60 ± 0.26 18.4
400 36.90 ± 0.68 37.90 ± 0.51 0.0 38.45 ± 0.29 0.0 38.65 ± 0.31 0.0 38.70 ± 0.29 5.8 38.60 13.3
Cymbopogon citratus
leaf
200 36.95 ± 0.28 37.90 ± 0.89 0.0 37.85 ± 0.18 21.1 37.45 ± 0.35* 69.7 37.20 ± 0.52* 86.9 37.00 ± 0.09** 97.4
400 37.00 ± 0.41 38.05 ± 0.62 0.0 37.70 ± 0.09 38.6 37.45 ± 0.18* 72.7 37.30 ± 0.56* 84.3 37.05 ± 0.22** 97.4
Citrus sinensis leaf 200 37.00 ± 0.22 38.00 ± 0.20 0.0 38.05 ± 0.25 7.9 37.85 ± 0.26* 48.5 37.55 ± 0.19* 71.2 37.35 ± 0.35* 82.1
400 37.05 ± 0.15 38.05 ± 0.31 0.0 38.25 ± 0.18 0.0 37.75 ± 0.11* 57.6 37.45 ± 0.55* 79.1 37.25 ± 0.28* 89.8
Ocimumgratissimum
leaf
200 37.00 ± 0.33 37.95 ± 0.46 0.0 37.90 ± 0.42 21.1 37.75 ± 0.19* 54.5 37.40 ± 0.38* 79.1 37.15 ± 0.52** 92.3
400 37.00 ± 0.81 37.95 ± 0.19 0.0 38.00 ± 0.19 12.3 37.75 ± 0.09* 54.5 37.45 ± 0.61* 76.4 37.10 ± 0.33** 94.9
Significant difference * - p < 0.05, ** - p < 0.001 when compared to the control
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Cc exhibited the best activity among all the extracts tested.
We also observed that pyrexia inhibition trends by the
constituent plant extracts and the standards were compar-
able in both methods.
Anti-inflammatory activity
The anti-inflammatory activities of the constituent plant
extracts of Nefang at different concentrations (100, 200
and 400 mgkg−1) were determined using Indomethacin (10
mgkg−1) as the standard. Results obtained have been sum-
marized in Table 3. These indicated significant inhibition
of carrageenan-induced inflammation in paws of experi-
mental rats when compared to the control. Inflammation
of the paw of experimental animals was observed 60 min
post carrageenan administration. In experimental rats
treated with the standard drug, the paw volumes were sig-
nificantly (p < 0.001) reduced, 240 min post administration,
giving a paw edema inhibition of 43.7 % when compared
to the control. After administration of the constituent plant
extracts of Nefang, only MiL exhibited a comparable anti-
inflammatory activity to that of the standard drug by
significantly (p < 0.001) reducing the inflamed rat paw vol-
umes by 40 % at all doses. Cp and MiB also exhibited sig-
nificant (p < 0.05) anti-inflammatory activities at lower
doses in experimental rats when compared to the control,
with approximately 28 – 30 % paw inhibition. Og, Pg, Cc
and Cs all showed moderate but significant (p < 0.05) anti-
inflammatory activities at lower doses, with paw inhibition
of approximately 20 %.
Antinociceptive activity
Effects on tail pressure
The antinociceptive activity of the constituent plant ex-
tracts of Nefang on tail-induced pressure in mice was
determined using an analgesy-meter. The percentage in-
hibition of induced pain in experimental mice, calculated
from their mean reaction times to gradual increase in
tail pressure has been summarized in Fig. 1. The results
obtained suggested that MiL, Og and Pg produced sig-
nificant (p < 0.001) percentage inhibition of the threshold
Table 3 Anti-inflammatory effect of the constituent plant extracts of Nefang on carrangeenan-induced paw edema in wistar rats
Treatment (Drug/Aqueous Extract) Dose (mg/kg) Increase in paw volumes [PV] (mL) and edema inhibition [EI] (%) over time (minutes)
x  SD; n ¼ 5ð Þ
0 60 120 180 240
PV EI PV EI PV EI PV EI
Normal Saline - 0 1.18 ± 0.08 0.0 1.28 ± 0.14 0.0 1.46 ± 0.13 0.0 1.56 ± 0.09 0.0
Indomethacin 10 0 1.17 ± 0.04 1.3 1.08 ± 0.03* 15.3 1.00 ± 0.10** 31.5 0.88 ± 0.03** 43.7
Mangifera indica bark 100 0 1.07 ± 0.11 9.7 1.13 ± 0.09* 11.4 1.19 ± 0.03* 18.8 1.12 ± 0.01** 28.3
200 0 1.15 ± 0.12 3.0 1.21 ± 0.02 5.5 1.32 ± 0.06* 9.9 1.24 ± 0.10* 20.6
400 0 1.18 ± 0.05 0.4 1.27 ± 0.04 0.8 1.36 ± 0.03 6.8 1.26 ± 0.06* 19.0
Mangifera indica leaf 100 0 1.04 ± 0.13 11.9 1.01 ± 0.08* 20.8 0.92 ± 0.08** 37.3 0.93 ± 0.06** 40.2
200 0 1.05 ± 0.03 11.4 1.11 ± 0.08* 13.3 0.91 ± 0.14** 37.7 0.95 ± 0.11** 39.2
400 0 1.05 ± 0.03 11.4 0.93 ± 0.03* 27.5 0.89 ± 0.06** 39.4 0.88 ± 0.08** 43.4
Psidium guajava leaf 100 0 1.04 ± 0.04 11.9 1.12 ± 0.10* 12.5 1.12 ± 0.06* 23.6 1.21 ± 0.04* 22.2
200 0 1.04 ± 0.07 11.9 1.14 ± 0.11* 11.0 1.13 ± 0.13* 22.6 1.23 ± 0.13* 21.2
400 0 1.08 ± 0.07 8.5 1.17 ± 0.10* 8.2 1.27 ± 0.15* 13.0 1.28 ± 0.05* 17.7
Carica papaya leaf 100 0 0.97 ± 0.03 17.8 1.04 ± 0.10* 18.4 1.15 ± 0.09** 21.2 1.10 ± 0.03** 29.3
200 0 1.10 ± 0.09 6.8 1.12 ± 0.17* 12.5 1.17 ± 0.13** 19.9 1.11 ± 0.05** 28.9
400 0 1.11 ± 0.07 6.4 1.19 ± 0.05 6.7 1.36 ± 0.11 7.2 1.32 ± 0.09* 15.1
Cymbopogon citratus leaf 100 0 1.08 ± 0.12 8.9 1.16 ± 0.04* 9.4 1.24 ± 0.11* 15.1 1.27 ± 0.03* 18.3
200 0 1.12 ± 0.04 5.1 1.17 ± 0.08* 8.2 1.20 ± 0.02* 18.2 1.34 ± 0.04* 13.8
400 0 1.15 ± 0.04 3.0 1.24 ± 0.01 3.1 1.42 ± 0.06 3.1 1.48 ± 0.09 5.1
Citrus sinensis leaf 100 0 1.15 ± 0.12 2.5 1.22 ± 0.03 4.7 1.24 ± 0.05* 15.1 1.27 ± 0.13* 18.6
200 0 1.17 ± 0.03 1.3 1.19 ± 0.04 7.1 1.35 ± 0.20 7.5 1.46 ± 0.16 6.4
400 0 1.17 ± 0.04 0.8 1.20 ± 0.03 6.3 1.45 ± 0.04 1.0 1.56 ± 0.13 0.0
Ocimum gratissimum leaf 100 0 1.06 ± 0.05 10.6 1.14 ± 0.07* 10.6 1.23 ± 0.04* 16.1 1.22 ± 0.05* 21.5
200 0 1.07 ± 0.06 9.3 1.16 ± 0.08* 9.4 1.23 ± 0.04* 16.1 1.24 ± 0.02* 20.3
400 0 1.17 ± 0.03 1.3 1.26 ± 0.04 1.2 1.31 ± 0.12 10.3 1.33 ± 0.08 14.5
Significant difference: compared to control; (*)-p < 0.05, (**)-p < 0.01
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pain by 177.3, 167.4 and 139.6 respectively, when com-
pared to the normal control 30 min after extract admin-
istration. This activity was comparable to that of the
standard drug, morphine (146.7 %). MiB and Cp had
moderate percentage pain inhibition of 107.7 and 106.3
respectively while Cs and Cc had weak activities. Two
hours post treatment, only MiL and Og still exhibited
good pain inhibition levels of 129.6 % and 112.2 % re-
spectively, comparable to 146.7 % for morphine. Pg and
MiB still exhibited moderate activities at 83.3 % and
77.4 %, while Cc, Cp and Cs exhibited very weak activ-
ities. Since all the extracts showed activity, they were all
subjected to further dose–response testing.
Tail flick response
The results of the tail flick response in mice and the cal-
culated percentage inhibition by the constituent plant
extracts of Nefang have been presented in Table 4. In ex-
perimental animals treated with the standard drug, para-
cetamol, the mean initial tail flicking time was 4.27 s.
The reaction time increased gradually after administra-
tion of the standard drug and a mean reaction time of
8.39 s was attained at the end of 60 min. This was con-
stant up to the end of 120 min. Analysis revealed that
Og, MiL, Pg and MiB exhibited dose-dependent in-
creases in reaction time. The reaction times after admin-
istration of MiL and Pg at doses of 600 and 1200 mgkg−1
bwt, were comparable to that of the standard group after
60 min and up to 120 min, whereas animals treated with
Og and MiB exhibited the same activity only at the high-
est dose of 1200 mgkg−1. The mean initial tail flicking
time resulted in a pain inhibition of 59.9 % after 30 min
to over 90 % after 60 min, which was constant to the
end of the experiment (120 min), when compared to the
reaction before drug administration. Pain inhibition (%)
at the highest doses for Og (113), MiL (108), Pg (84) and
MiB (88) were comparable to that of paracetamol (97).
At lower doses, we observed significantly (p < 0.05) lower
activities of these extracts when compared to the standard.
In animals administered Cp and Cc, we observed moder-
ate reaction times at doses up to 600 mgkg−1 bwt, though
significantly (p < 0.05) low when compared to the stand-
ard. At higher doses as well as in animals treated with Cs
(all doses), reaction times were significantly (p < 0.001)
low, suggesting that they exhibited lower activities.
Hot plate response
The effect of the constituent plants of Nefang on heat-
induced nociceptive pain in mice was determined using
the hot plate method (Table 5). Piroxicam (20 mgkg−1)
and pethidine (50 mgkg−1) were used as standards. The re-
action times of experimental animals were taken after 30,
60 and 120 min. Piroxicam-treated rats exhibited reactions
times of 19.31, 47.49 and 47.41 s and pethidine-treated
rats, 18.90, 19.15 and 20.02 s. These produced significant
percentage increase in the threshold of pain by 87.7, 361.6,
360.8 (p < 0.01) and 100.2, 102.8, 112.0 (p < 0.05) respect-
ively, suggesting that piroxicam exhibited a better antino-
ciceptive activity than pethidine relative to the control.
After administration of the plants extracts, we observed
a dose-dependent increase in reaction times in animals
treated with Og, MiL, MiB and Pg between 30 to 120 min,
with Og showing the best reaction time of 28.98, 29.94
and 32.55 s after 30, 60 and 120 s respectively, at the high-
est dose of 1200 mgkg−1. This corresponds to an increased
percentage pain inhibition of 187.7, 197.2 and 223.1 dur-
ing the experimental time; this was significantly (p < 0.001)
lower than that of piroxicam after 120 min and higher
than that of pethidine (p < 0.001). MiL, MiB and Pg all
showed significantly (p < 0.001) higher pain inhibition at
1200 mgkg−1 in experimental animals when compared to
animals that were treated with pethidine, though lower
when compared to animals that were administered piroxi-
cam. Cp, Cc and Cs exhibited weak activities (p < 0.001).
Fig. 1 Antinociceptive effect of the constituent plant extracts of Nefang on tail-induced pressure in mice. Significant difference: * - p < 0.001 when
compared to normal control; # - p < 0.05 when compared to the standard
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Discussion
Infections such as malaria, caused by Plasmodium spe-
cies usually trigger a cascade of unpleasant physiological
changes in the host such as oxidative stress, pyrexia, in-
flammation and nociception. Biological agents that can
act against these and other relevant effects can comple-
ment therapeutic activities of antiparasitic and anti-
microbial agents. Activities evaluated in the constituent
plants of Nefang included antipyretic, anti-inflammatory
and antinociceptive.
Pyrexia is a result of the secondary impact of infection,
tissue damage, inflammation, graft rejection, malignancy or
other diseased states including malaria. Brewer’s yeast and
D-amphetamine are commonly used to induce pyrexia in
rats and mice [19]. Brewer’s yeast induces pyrexia by in-
creasing the synthesis of prostaglandins (PGE2). The
infections or damaged tissue serves as a pyrogenic
stimulus and the pyrogens are phagocytized by the
Kupffer cells, monocytes and macrophages leading to the
release of pro-inflammatory mediators (cytokines). These
cause an increase in the synthesis of prostaglandins near
pre-optic hypothalamus area thereby triggering the hypo-
thalamus to elevate the set point of normal body
temperature [20]. Amphetamine on the other hand, acts
on the brain causing the release of biogenic amines from
their storage sites in nerve terminals. This results in in-
creased level of cyclic-Adenosine monophosphate (cAMP)
and subsequent synthesis of prostaglandins from arachi-
donic acids produced in neurons receptor-mediated hy-
drolysis of phospholipids, leading to hyperthermia [21].
Most of the antipyretic drugs inhibit cyclooxygenase
(COX-2) expression thereby inhibiting prostaglandin bio-
synthesis and reducing elevated body temperature. They
are, however, toxic to the hepatic cells, glomeruli, cortex
of the brain and heart muscle. Natural antipyretic remed-
ies with minimal toxicity are therefore essential.
The results of this study show that Cc, Og, MiL, MiB and
Cs aqueous extracts significantly reduced amphetamine
and brewer’s yeast induced hyperthermia in the rats at 120,
180 and 240 min post administration. This hypothermic
activity might have been achieved by their action on COX-
2, thereby reducing the concentration of prostaglandin in
Table 4 Antinociceptive effect of the constituent plant extracts of Nefang on electric heat-induced pain on the tails of mice
Treatment (Drug/Aqueous Extract) Dose (mg/kg) Tail flick reaction time [RT] (sec) and pain inhibition [PI] (%) at designated time intervals (minutes)
(x ± SD, n = 5)
0 30 60 90 120
RT RT PI RT PI RT PI RT PI
Paracetamol 150 4.27 ± 0.38 6.82 ± 0.28 60.0 8.39 ± 0.20 96.8 8.43 ± 0.36 97.6 8.26 ± 0.23 93.5
Mangifera indica bark 300 4.30 ± 0.38 5.62 ± 0.24 31.7 6.47 ± 0.37 51.7 6.30 ± 0.31* 47.6 5.66 ± 0.24* 32.7
600 4.30 ± 0.38 5.96 ± 0.49 39.6 6.46 ± 0.37* 51.5 6.35 ± 0.25* 48.8 6.25 ± 0.20* 46.5
1200 4.30 ± 0.38 7.20 ± 0.27 68.8 8.05 ± 0.41 88.7 6.99 ± 0.29 63.8 6.98 ± 0.06 63.6
Mangifera indica leaf 300 4.32 ± 0.38 6.47 ± 0.25 51.8 7.59 ± 0.43 77.9 6.19 ± 0.37* 45.1 6.08 ± 0.20* 42.6
600 4.32 ± 0.38 6.95 ± 0.14 62.9 7.80 ± 0.21 82.2 7.78 ± 0.76 82.4 7.47 75.1
1200 4.32 ± 0.38 7.09 ± 0.48 66.1 8.89 ± 0.41 108.5 8.64 ± 0.44 102.6 8.42 ± 0.36 97.3
Psidium guajava leaf 300 4.25 ± 0.38 6.32 ± 0.35 49.3 6.49 ± 0.29 52.2 6.38 ± 0.17* 49.6 5.26 ± 0.17* 23.2
600 4.25 ± 0.38 7.63 ± 0.38 78.8 7.73 ± 0.27 81.2 7.42 ± 0.46 73.8 6.45 ± 0.31* 51.2
1200 4.25 ± 0.38 7.82 ± 0.35 83.3 7.88 ± 0.19 84.7 7.54 ± 0.37 76.7 7.08 ± 0.05 65.9
Carica papaya leaf 300 4.29 ± 0.38 5.80 ± 0.70* 36.1 6.35 ± 0.31* 48.9 6.19 ± 0.53* 45.1 5.98 ± 0.17* 40.2
600 4.29 ± 0.38 6.73 ± 0.87 57.8 6.65 ± 0.52 55.8 6.34 ± 0.48* 48.7 6.16 ± 0.27* 44.4
1200 4.29 ± 0.38 5.04 ± 0.62* 18.2 5.12 ± 0.39* 20.1 5.39 ± 0.63* 26.3 5.36 ± 0.29* 25.7
Cymbopogon citratus leaf 300 4.31 ± 0.38 5.42 ± 0.50* 27.0 6.22 ± 0.28* 45.8 5.48 ± 0.09 28.4 5.00 ± 0.38* 17.3
600 4.31 ± 0.38 6.00 ± 0.90 40.6 6.43 ± 0.33 50.8 5.98 ± 0.30* 40.1 5.74 ± 0.38* 34.5
1200 4.31 ± 0.38 5.87 ± 0.32 37.6 6.56 ± 0.41 53.7 5.80 ± 0.25* 36.0 5.69 ± 0.32* 33.4
Citrus sinensis leaf 300 4.27 ± 0.38 4.76 ± 0.17* 11.6 4.77 ± 0.31** 11.7 4.61 ± 0.32** 8.0 4.30 ± 0.22** 0.9
600 4.27 ± 0.38 4.92 ± 0.28* 15.4 4.59 ± 0.33** 7.5 4.65 ± 0.42** 9.1 4.35 ± 0.15** 1.9
1200 4.27 ± 0.38 4.55 ± 0.30* 6.7 4.35 ± 0.24** 1.9 4.38 ± 0.15** 2.8 4.26 ± 0.22** 0.0
Ocimum gratissimum leaf 300 4.33 ± 0.38 5.58 ± 0.38 30.8 6.33 ± 0.50* 48.5 6.45 ± 0.26* 51.2 5.85 ± 0.14* 37.0
600 4.33 ± 0.38 6.03 ± 0.76 41.3 6.60 ± 0.54 54.7 7.09 ± 0.68 66.1 6.19 ± 0.30* 45.1
1200 4.33 ± 0.38 7.50 ± 0.55 75.9 7.81 ± 0.29 83.0 9.09 ± 0.69 113.0 7.91 ± 0.38 85.5
Significant difference * - p < 0.05, ** - p < 0.001 when compared to the standard control
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the brain or by enhancing the inherent production of the
body’s own antipyretic substances such as arginine and
vasopressin [22]. An alternative could have been by vaso-
dilation of superficial blood vessels leading to increased
dissipation of heat as a result of a reset of the hypothalamic
temperature control centre [23].
Inflammation is a common phenomenon in malaria in-
fection and it is the reaction of living tissues towards injury.
The carrageenan-induced paw edema is a prototype for the
exudative phase of acute inflammatory effects. The devel-
opment of edema in the rat paw after the injection of car-
rageenan has been described as a biphasic event [24]. The
initial phase which starts immediately after injection and
reduces within one hour, is attributed to the release of his-
tamine and serotonin, while the second phase of swelling
which begins at one and remains through three hours, is
due to the release of prostaglandin-like substances [25].
The second phase of edema is sensitive to both clinically
useful steroidal and non-steroidal anti-inflammatory drugs
(NSAIDs). Generally NSAIDs strongly inhibit the second
phase of carrageenan-induced edema. The significant in-
hibition of paw edema in rats byMiL, Cp and MiB aqueous
extracts suggest that they may contain biologically active
substances with anti-inflammatory properties. The signifi-
cant anti-inflammatory activities exhibited may be due to
the inhibition of any inflammatory mediators, and this
might contribute greatly to the antimalarial activity of
Nefang. The co-existence of antinociceptive and anti-
inflammatory activities observed in Nefang, are properties
shared by most NSAIDs, particularly the salicylates and
their derivatives. The therapeutic benefits of traditional
remedies are often attributed to a combination of active
constituents [26].
Increased nociception is a common phenomenon during
Plasmodium infection. Measuring antinociceptive activity
is based on the principle that inflammation increases the
sensitivity to pain and that this sensitivity is susceptible to
modification by analgesics. Inflammation decreases the
Table 5 Antinociceptive effect of the constituent plant extracts of Nefang on heat-induced nociceptive pain in mice
Treatment (Drug/Aqueous Extract) Dose (mg/kg) Mice reaction time [RT] (sec) and pain inhibition [PI] (%) at designated time intervals (minutes)
x  SD; n ¼ 4ð Þ
0 min 30 min 60 min 120 min
RT PI RT PI RT PI RT PI
Normal Saline - 9.51 ± 1.24 0 10.70 ± 1.07 12.6 10.56 ± 0.74 11.0 11.28 ± 0.67 18.6
Piroxicam 20 10.29 ± 0.61 0 19.31 ± 1.34* 87.7 47.49 ± 0.76** 361.6 47.41 ± 0.66** 360.8
Pethidine 50 9.44 ± 0.17 0 18.90 ± 0.92* 100.2 19.15 ± 0.77* 102.8 20.02 ± 1.14* 112.0
Mangifera indica bark 300 9.93 ± 0.25 0 13.90 ± 1.21 40.0 21.75 ± 1.28* 119.0 20.81 ± 0.68* 109.6
600 9.63 ± 0.69 0 13.65 ± 0.34 41.8 22.23 ± 0.71* 131.0 22.61 ± 0.70* 134.8
1200 10.05 ± 0.26 0 22.91 ± 0.89* 128.0 27.29 ± 0.62* 171.7 23.79 ± 1.81* 136.8
Mangifera indica leaf 300 11.11 ± 0.94 0 12.80 ± 0.58 15.2 16.71 ± 0.50* 50.4 16.11 ± 0.26 45.0
600 11.21 ± 0.48 0 23.72 ± 0.88* 111.6 24.25 ± 1.17* 116.3 21.71 ± 0.68* 93.7
1200 10.70 ± 0.53 0 23.41 ± 1.07* 118.8 32.75 ± 0.25** 206.1 28.56 ± 0.13* 167.0
Psidium guajava leaf 300 10.09 ± 0.45 0 14.41 ± 0.73 42.8 14.57 ± 0.68 44.4 13.79 ± 1.14 36.6
600 9.84 ± 0.34 0 14.86 ± 0.51 51.1 15.47 ± 0.21 57.3 18.33 ± 0.29 86.3
1200 10.29 ± 0.53 0 21.27 ± 0.46* 106.7 26.29 ± 0.24* 155.4 24.22 ± 0.57* 135.3
Carica papaya leaf 300 9.63 ± 0.48 0 11.46 ± 0.94 19.0 11.51 ± 0.36 19.5 10.79 ± 0.61 12.0
600 9.45 ± 0.40 0 12.28 ± 0.84 30.0 12.51 ± 0.38 32.5 11.01 ± 0.72 16.6
1200 9.90 ± 0.77 0 12.45 ± 0.28 25.8 17.42 ± 0.25* 76.0 16.91 ± 0.62 70.8
Cymbopogon citratus leaf 300 10.07 ± 0.34 0 11.00 ± 0.36 9.2 11.71 ± 0.38 16.3 15.28 ± 0.56 51.7
600 9.78 ± 0.34 0 13.34 ± 0.77 36.4 13.02 ± 0.45 33.1 16.08 ± 0.72 64.4
1200 10.05 ± 0.33 0 15.24 ± 1.12 51.6 14.81 ± 1.10 47.3 18.85 ± 0.57 75.0
Citrus sinensis leaf 300 9.90 ± 0.44 0 13.24 ± 0.60 33.7 12.83 ± 0.24 29.6 13.27 ± 0.70 34.1
600 9.86 ± 0.46 0 15.10 ± 0.61 53.2 14.99 ± 0.90 52.1 13.60 ± 0.43 38.0±
1200 9.73 ± 0.33 0 14.21 ± 0.67 46.0 16.34 ± 0.60* 67.9 15.03 ± 1.37 54.5
Ocimum gratissimum leaf 300 9.63 ± 0.36 0 13.66 ± 0.30 41.8 18.15 ± 0.89* 88.5 18.98 ± 0.92 97.0
600 9.79 ± 0.28 0 13.66 ± 0.89 39.5 22.83 ± 0.20* 133.2 24.29 ± 1.17* 148.1
1200 10.07 ± 0.70 0 28.98 ± 0.64* 187.7 29.94 ± 0.43** 197.2 32.55 ± 1.47** 223.1
Significant difference * - p < 0.05; ** - p < 0.001 when compared to the control
Tarkang et al. BMC Complementary and Alternative Medicine  (2015) 15:174 Page 9 of 11
pain reaction threshold and this low pain reaction thresh-
old is readily elevated by different types of analgesics [15].
Antinociceptive properties were studied using models that
could provide different types of noxious stimuli. These
were mechanical pressure on the tail, thermal stimuli
using the radiant heat-induced nociceptive pain on the tail
and heat-induced nociceptive pain on the paws of mice.
Mechanical pain induced by the analgesy-meter provides a
model for the study of non-inflammatory pain. The
analgesy-meter antinociceptive test is useful in elucidating
centrally mediated antinociceptive responses, which fo-
cuses mainly on changes above the spinal cord level [27].
The significant increase in pain threshold produced by the
extracts in the analgesy-meter test suggests involvement
of central pain pathways. Thermal tests have several ad-
vantages including the sensitivity to strong analgesics and
limited tissue damage [28]. Furthermore, they utilize
phasic stimulus of high intensities mimicking responses in
conditions that involve high threshold pain of short dur-
ation. However, a disadvantage of this model is that since
it is short lasting, it does not assess modulatory mecha-
nisms that may be triggered by the stimulus itself [29] and
is a less valid model for clinical pain [30]. The results ob-
tained indicate that Og, MiL, Pg and MiB can significantly
inhibit responses to mechanical and thermal stimuli. The
inhibition of thermal stimuli was dose dependent, thus in-
dicating that these extracts, at the doses administered, had
strong antinociceptive activities and can contribute signifi-
cantly to the antimalarial effect of Nefang.
The results obtained in these studies are consistent with
previously reports on the pharmacological activities of O.
gratissimum [31], M. indica bark and leaf [32, 33], C. pa-
paya [34] and P. guajava [35]. These findings lend
pharmacological support to the reported folkloric uses of
Nefang in the treatment of malaria and the role played by
each of them.
Conclusion
The results obtained suggest that the constituent plants
possess biologically active compounds with antipyretic,
anti-inflammatory and antinociceptive activities. These
findings define the role of each constituent plant, sug-
gesting that these pharmacological activities are essential
in the symptomatic management of malaria fever. These
also provide scientific evidence that the therapeutic ef-
fects of Nefang are as a result of the synergy between
antiplasmodial and other pharmacological activities of its
constituent plants, thereby justify the folk use of Nefang
for the treatment malaria fever. This could be useful in its
subsequent development for clinical application.
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